Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Catherine Yang + 846 word(s) 846 2020-12-15 07:16:44

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Yang, C. Autosomal Dominant Hyper-IgE Syndrome. Encyclopedia. Available online: https://encyclopedia.pub/entry/4891 (accessed on 27 September 2026).
Yang C. Autosomal Dominant Hyper-IgE Syndrome. Encyclopedia. Available at: https://encyclopedia.pub/entry/4891. Accessed September 27, 2026.
Yang, Catherine. "Autosomal Dominant Hyper-IgE Syndrome" Encyclopedia, https://encyclopedia.pub/entry/4891 (accessed September 27, 2026).
Yang, C. (2020, December 24). Autosomal Dominant Hyper-IgE Syndrome. In Encyclopedia. https://encyclopedia.pub/entry/4891
Yang, Catherine. "Autosomal Dominant Hyper-IgE Syndrome." Encyclopedia. Web. 24 December, 2020.
Autosomal Dominant Hyper-IgE Syndrome
Edit

Autosomal dominant hyper-IgE syndrome (AD-HIES), formerly known as Job syndrome, is a condition that affects several body systems, particularly the immune system. Recurrent infections are common in people with this condition. Affected individuals tend to have frequent bouts of pneumonia, which are caused by certain kinds of bacteria that infect the lungs and cause inflammation. Inflammation is a normal immune system response to injury and foreign invaders (such as bacteria). However, excessive inflammation can damage body tissues. Recurring pneumonia often results in the formation of air-filled cysts (pneumatoceles) in the lungs. Frequent skin infections and an inflammatory skin disorder called eczema are also very common in AD-HIES. These skin problems cause rashes, blisters, accumulations of pus (abscesses), open sores, and scaling.

genetic conditions

References

  1. Béziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, Pellier I, Zoghi S, Baris S, Keles S, Gray P, Du N, Wang Y, Zerbib Y, Lévy R, Leclercq T, About F, Lim AI, RaoG, Payne K, Pelham SJ, Avery DT, Deenick EK, Pillay B, Chou J, Guery R, BelkadiA, Guérin A, Migaud M, Rattina V, Ailal F, Benhsaien I, Bouaziz M, Habib T,Chaussabel D, Marr N, El-Benna J, Grimbacher B, Wargon O, Bustamante J, BoissonB, Müller-Fleckenstein I, Fleckenstein B, Chandesris MO, Titeux M, Fraitag S,Alyanakian MA, Leruez-Ville M, Picard C, Meyts I, Di Santo JP, Hovnanian A, SomerA, Ozen A, Rezaei N, Chatila TA, Abel L, Leonard WJ, Tangye SG, Puel A, Casanova JL. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependentSTAT3 transcription and activity. Sci Immunol. 2018 Jun 15;3(24). pii: eaat4956. doi: 10.1126/sciimmunol.aat4956.
  2. Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, Thumerelle C,Oksenhendler E, Boutboul D, Thomas C, Hoarau C, Lebranchu Y, Stephan JL, Cazorla C, Aladjidi N, Micheau M, Tron F, Baruchel A, Barlogis V, Palenzuela G, Mathey C,Dominique S, Body G, Munzer M, Fouyssac F, Jaussaud R, Bader-Meunier B, Mahlaoui N, Blanche S, Debré M, Le Bourgeois M, Gandemer V, Lambert N, Grandin V, Ndaga S,Jacques C, Harre C, Forveille M, Alyanakian MA, Durandy A, Bodemer C, Suarez F,Hermine O, Lortholary O, Casanova JL, Fischer A, Picard C. Autosomal dominantSTAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinicalfeatures from a French national survey. Medicine (Baltimore). 2012Jul;91(4):e1-19. doi: 10.1097/MD.0b013e31825f95b9.
  3. Farmand S, Sundin M. Hyper-IgE syndromes: recent advances in pathogenesis,diagnostics and clinical care. Curr Opin Hematol. 2015 Jan;22(1):12-22. doi:10.1097/MOH.0000000000000104. Review.
  4. Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, Matta JR, Hadigan C, Pettigrew RI, Holland SM, Gharib AM. Coronary artery abnormalities in Hyper-IgEsyndrome. J Clin Immunol. 2011 Jun;31(3):338-45. doi: 10.1007/s10875-011-9515-9.
  5. Freeman AF, Collura-Burke CJ, Patronas NJ, Ilcus LS, Darnell D, Davis J, Puck JM, Holland SM. Brain abnormalities in patients with hyperimmunoglobulin Esyndrome. Pediatrics. 2007 May;119(5):e1121-5.
  6. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007May;119(5):1234-40.
  7. Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, Bulashevska A, Proietti M, Fröbel P, Nöltner C, Yang L, Rojas-Restrepo J, Langer N, Winzer S, Engelhardt KR, Glocker C, Pfeifer D, Klein A, Schäffer AA, Lagovsky I, Lachover-Roth I, Béziat V, Puel A, Casanova JL, Fleckenstein B, Weidinger S,Kilic SS, Garty BZ, Etzioni A, Grimbacher B. ZNF341 controls STAT3 expression andthereby immunocompetence. Sci Immunol. 2018 Jun 15;3(24). pii: eaat4941. doi:10.1126/sciimmunol.aat4941.
  8. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF,Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB,Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007 Oct 18;357(16):1608-19.
  9. Hox V, O'Connell MP, Lyons JJ, Sackstein P, Dimaggio T, Jones N, Nelson C,Boehm M, Holland SM, Freeman AF, Tweardy DJ, Olivera A, Metcalfe DD, Milner JD.Diminution of signal transducer and activator of transcription 3 signalinginhibits vascular permeability and anaphylaxis. J Allergy Clin Immunol. 2016Jul;138(1):187-199. doi: 10.1016/j.jaci.2015.11.024.J Allergy Clin Immunol. 2017 Jul;140(1):320.
  10. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, ArigaT, Pasic S, Stojkovic O, Metin A, Karasuyama H. Dominant-negative mutations inthe DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007 Aug30;448(7157):1058-62.
  11. Renner ED, Torgerson TR, Rylaarsdam S, Añover-Sombke S, Golob K, LaFlam T, ZhuQ, Ochs HD. STAT3 mutation in the original patient with Job's syndrome. N Engl J Med. 2007 Oct 18;357(16):1667-8.
  12. Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung MY, Barber JS,Freeman AF, Holland SM, O'Brien M, Jones N, Nelson CG, Wisch LB, Kong HH, DesaiA, Farber O, Gilfillan AM, Rivera J, Milner JD. Diminished allergic disease inpatients with STAT3 mutations reveals a role for STAT3 signaling in mast celldegranulation. J Allergy Clin Immunol. 2013 Dec;132(6):1388-96. doi:10.1016/j.jaci.2013.08.045.2014 Apr;133(4):1232. Nelson, Celeste G [added].
More
Upload a video for this entry
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Catherine Yang
View Times: 886
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service